Alzenau, Germany

Jürgen Engel


Average Co-Inventor Count = 4.1

ph-index = 6

Forward Citations = 106(Granted Patents)


Company Filing History:


Years Active: 2001-2004

Loading Chart...
15 patents (USPTO):Explore Patents

Title: Jürgen Engel: Innovator in Peptide Technology

Introduction

Jürgen Engel is a prominent inventor based in Alzenau, Germany. He has made significant contributions to the field of peptide technology, holding a total of 15 patents. His work focuses on innovative methods and applications that have the potential to impact medical treatments.

Latest Patents

Among his latest patents is the development of an oligopeptide lyophilisate, which includes a novel method of preparation and its use in treating female infertility and for gonad protection. This lyophilizate is created by dissolving Cetrorelix in a 30% v/v acetic acid solution, which is then transferred to water and freeze-dried. Another significant patent involves a method for synthesizing peptide salts, which details the process of reacting an acid addition salt of a basic starting peptide in the presence of a diluent using a mixed bed ion exchanger. This method allows for the formation of a free basic peptide, followed by the separation of the ion exchanger and the desired acid addition salt of the peptide.

Career Highlights

Jürgen Engel has worked with notable companies in the pharmaceutical industry, including Asta Medica and Zentaris AG. His experience in these organizations has contributed to his expertise in peptide research and development.

Collaborations

Throughout his career, Jürgen has collaborated with esteemed colleagues such as Bernd Nickel and Thomas Klenner. These partnerships have fostered innovation and advancement in his field.

Conclusion

Jürgen Engel's contributions to peptide technology and his innovative patents highlight his role as a leading inventor in the medical field. His work continues to pave the way for advancements in treatments for various health conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…